Citadel Advisors’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Citadel Advisors’s Portfolio RNA Stock Details RNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-6,500	Closed	-$122K	–	9255
2014 Q4	$122K	Buy	6,500 +6,200	+2,067%	+$88.1K	﹤0.01%	6479
2014 Q3	$3K	Sell	300 -1,800	-86%	-$17.1K	﹤0.01%	7986
2014 Q2	$27K	Sell	2,100 -6,400	-75%	-$51.9K	﹤0.01%	7151
2014 Q1	$48K	Sell	8,500 -7,300	-46%	-$45.3K	﹤0.01%	6812
2013 Q4	$74K	Buy	15,800 +11,500	+267%	+$52.4K	﹤0.01%	5825
2013 Q3	$28K	Buy	+4,300	New	+$101K	﹤0.01%	6070

Citadel Advisors's RNA Position: Q4 2014 in Review

Citadel Advisors sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q4 2014, closing a stake of 2,148 shares — an estimated $30.5K sold.

Citadel Advisors first reported a position in RNA in Q3 2013 and held it in 5 quarters. The position peaked at $88K in Q4 2013. 47 funds tracked by Wall St. Rank hold RNA as of Q4 2014.

Citadel Advisors reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q4 2014 after selling out during the quarter.
Citadel Advisors sold 2,148 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q4 2014, an estimated $30.5K.
Citadel Advisors first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2013 and held it in 5 quarters.
Citadel Advisors's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $88K in Q4 2013.
47 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q4 2014.

Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.